Sign In
Buy JAZZ
$252.86
-5.52 (-2.14%)
At Close: Jul 31, 2026
Will There Be More M&A for the Cannabis Industry in 2021?
06:55am, Friday, 12'th Feb 2021
The sector is hot again on the heels of two large deals.
Cannabis Stocks Rise on Hopes of Federal Legalization in US
11:41am, Wednesday, 10'th Feb 2021
Cannabis stocks seem poised to gain on hopes of removal of the federal ban on cannabis products under the new administration.
Cannabinoid Capital (Podcast)
09:00am, Wednesday, 10'th Feb 2021
Cannabinoid Capital (Podcast)
Cardiol CEO sees bright future for pharmaceutically produced cannabidiol after blockbuster Jazz-GW Pharmaceutical deal
02:54pm, Sunday, 07'th Feb 2021
A blockbuster deal announced earlier this week could be a sign of a bright future for cannabidiol-oriented pharmaceutical companies. On Wednesday, cancer therapy developer Jazz Pharmaceuticals PLC (NA
Willow Biosciences is set to benefit from Jazz Pharmaceuticals acquisition of GW Pharmaceuticals
02:54pm, Sunday, 07'th Feb 2021
Jazz Pharmaceuticals PLC's (NASDAQ:JAZZ) recently-announced deal to acquire cannabis-derived drug maker GW Pharmaceuticals plc (NASDAQ:GWPH) for US$7.2 billion in cash and stock has boosted investor
4 Green Flags For Jazz Pharmaceuticals' Buyout of GW Pharmaceuticals
06:30am, Saturday, 06'th Feb 2021
Jazz is paying $7.2 million to buy the maker of CBD-derived drug Epidiolex. Is it a smart deal?
Cannabis Stocks Fly High On Biden Administration Potential
12:26pm, Friday, 05'th Feb 2021
Welcome back to our weekly series, Sc haeffer's Cannabis Stock News Update, where we recap what happened in the world of marijuana stocks last week, and look ahead to how the cannabis industry will d
Biogen, Fortinet, Kohl's, Pinterest, Snap and More Friday Afternoon Analyst Calls
11:50am, Friday, 05'th Feb 2021
With the trading day about halfway over, the broad markets were trading sideways into the weekend.
Jazz Pharmaceuticals: GW Pharmaceuticals Acquisition Makes Sense
11:45am, Friday, 05'th Feb 2021
Jazz made a bold bet with the acquisition of GW Pharmaceuticals.
Is Now The Time to Buy Jazz Pharmaceuticals Stock?
07:20am, Friday, 05'th Feb 2021
This troubled biopharma is making a multi-billion dollar bet on the cannabis industry in hopes of a turnaround.
Jazz Pharmaceuticals to Acquire Cannabis Drug Company
02:23pm, Wednesday, 03'rd Feb 2021
The deal to buy GW Pharmaceuticals creates a leader in neuroscience.
Pot Stocks Are Wednesday's Big Stock Market Winners. Will They Disappoint Shareholders in the End?
12:18pm, Wednesday, 03'rd Feb 2021
In a quiet market, marijuana companies stood out.
GWPH Stock: 12 Things to Know About the GW Pharma-Jazz Pharma Deal
11:35am, Wednesday, 03'rd Feb 2021
GW Pharmaceuticals (GWPH) stock is soaring higher on Wednesday following news that Jazz Pharmaceuticals (JAZZ) is acquiring the company. The post GWPH Stock: 12 Things to Know About the GW Pharma-Jazz
Jazz Pharma adds cannabis-based drug in $7.2 billion deal for GW Pharma
11:27am, Wednesday, 03'rd Feb 2021
Jazz Pharmaceuticals Plc said on Wednesday it would buy GW Pharmaceuticals plc in a $7.2 billion cash-and-stock deal to bolster its neuroscience business by adding a cannabis-based epilepsy treatment.
Cramer on Jazz Pharmaceuticals buying GW Pharma for $7.2 billion
10:03am, Wednesday, 03'rd Feb 2021
Jazz Pharmaceuticals said on Wednesday it would buy GW Pharmaceuticals in a $7.2 billion cash-and-stock deal to bolster its neuroscience business by adding cannabis-based epilepsy treatment. CNBC's Ji
